GuilhermeRabinowitsMD

Endocrine Cancer, Head & Neck Cancer

Medical Oncologist, Head and Neck - Endocrine Department at Moffitt Cancer Center

Overview of Dr. Rabinowits

Dr. Guilherme Rabinowits is a medical oncologist in Tampa, FL. He received his medical degree from Technical-Educational Foundation Souza Marques School Of Medicine and has been in practice for over 10 years. He specializes in cancers located in the mouth, throat, skin, thyroid, adrenal and salivary glands.

Office
12902 Magnolia Drive
Tampa, FL 33612
Book by Phone+1(209) 643-4331

Education & Training

University of Louisville School of MedicineFellowship, Hematology and Medical Oncology, 2006 - 2009
Lahey ClinicResidency, Internal Medicine, 2004 - 2006
MetroWest Medical CenterInternship, Internal Medicine, 2003 - 2004
Tech- Ed Fndn Souza Marques Sch MedClass of 2000

Certifications & Licensure

FL State Medical License 2017 - 2026
MA State Medical License 2011 - 2018
KY State Medical License 2008 - 2012
American Board of Internal Medicine Medical Oncology

Clinical Trials

Cabozantinib in Recurrent/Metastatic Merkel Cell Carcinoma Start of enrollment: 2014 Feb 01
Terminated
Phase 2
MLN0128 in Recurrent/Metastatic Merkel Cell Carcinoma Start of enrollment: 2015 Oct 01
Completed
Phase 1, Phase 2
Cemiplimab/Peg-Interferon-α in Advanced CSCC Start of enrollment: 2023 Jul 01
Withdrawn
Phase 1
Roles: Contact, Principal Investigator

Publications & Presentations

PubMed

CASE (CemiplimAb-rwlc Survivorship and Epidemiology): a study in advanced basal cell carcinoma.
Soo J Park, David M Ellison, Ryan Weight, Jade Homsi, Guilherme Rabinowits
Future Oncology. 2025-01-11
Hypofractionated versus standard fractionation radiotherapy for merkel cell carcinoma.
Lorein Gonzalez, Muni Rubens, Sreenija Yarlagadda, Guilherme Rabinowits, Noah S Kalman
Radiation Oncology. 2024-10-11
5 citations
Phase I Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced Melanoma.
Omid Hamid, Karl D Lewis, Amy Weise, Meredith McKean, Kyriakos P Papadopoulos
Journal of Clinical Oncology. 2024-08-20

Press Mentions

How Gut Bacteria Can Boost Cancer Immunotherapy EfficacyMarch 16th, 2023
Nearly Half of Parents Say They Have Leftover Prescription Medications at HomeOctober 24th, 2022
Immunotherapy Drug Opdivo Shows Promise in Treating Advanced Skin CancerOctober 24th, 2022
Join now to see all

Professional Memberships

Insurance Accepted

Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS Massachusetts Blue Care Elect PPO
BCBS New Mexico PPO
BCBS Oklahoma BlueChoice
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Coventry Oklahoma
First Health PPO
Great West PPO
Harvard Pilgrim HMO
Humana ChoiceCare Network PPO
Lovelace Health Plan PPO
Multiplan PHCS PPO
Multiplan PPO
Presbyterian Commercial
Tufts Health Plan PPO
UniCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment